An 80 kDa protein was purified from calf bone by HCl-demineralization followed by 0n5 M EDTA\1n0 M NaCl extraction and sequential chromatography on DE-52, hydroxyapatite, and TSK-gel G3000SW HPLC columns. From the DE-52 column the protein was eluted at three different fractions, of which one further separated into two fractions on the hydroxyapatite column, indicating that the protein is present in four different molecular forms designated as 80 k-I-1, k-I-2, k-II, k-III. The N-terminal sequence analysis of all four forms gave the same sequence, SEQYNQEPNNV. Several tryptic internal peptides were also generated, purified and sequenced, leading to the identification of several repeat sequences, IFLGXXEI. Homology searching of the N-terminal and internal sequences indicates that this is a novel protein. Both 80 k
INTRODUCTION
In addition to a major collagen type-I matrix, approximately 90 %, bone contains several other non-collagenous extracellular matrix (ECM) proteins (10 %). Of the non-collagenous proteins, the glycosylated phosphoproteins of ECM, of which probably the best known and characterized are osteopontin (OPN) and bone sialoprotein (BSP) [1] [2] [3] [4] [5] , have been the subject of intense study in the recent years. The conceptual considerations and in itro studies postulated importance of these phosphoproteins in initiation, regulation and stability of hydroxyapatite crystals [6] [7] [8] , and their involvement in cell attachment and bone resorption [9] [10] [11] [12] [13] [14] [15] are probably responsible for the extensive studies being carried out in an attempt to understand some of the biological functions of these proteins. The importance of covalently-bound phosphates on the ECM phosphoproteins in mineral deposition has been postulated and supported by studies initially in controlled in itro nucleation experiments, whereby complexes of chemically and structurally native bone collagen and bone phosphoproteins markedly influenced the rate of nucleation of Ca-P apatite crystals as a function of the total phosphoserine and phosphothreonine contents of the complex [8] . Studies in itro using BSP and OPN indicated that while BSP appears to induce Ca-P apatite formation [16] OPN lacks this property or is inhibitory [16, 17] . These studies continue to be of interest and present different results from study to study ;
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with Rhodamine B specific for phosphoproteins. The four forms contained different contents of neutral sugars ranging from 5n5 to 26 % (w\w protein) and " 1n7 % sialic acid. These data indicated that the 80 kDa protein exists in four isomeric forms, at least based on the different post-translational modifications. The evaluation of the 80 kDa glycosylated phosphoprotein under alkylating, reducing and non-reducing conditions indicated that this protein undergoes polymerization through intermolecular disulphide bonds. Furthermore, the 80 kDa protein and osteonectin (ON), both of which are cysteine-rich proteins, can crosslink with each other via disulphide bonds, and this process can be induced to take place in itro under experimental conditions. The occurrence of such a phenomenon in i o was confirmed from the presence of similar high M r components containing both 80 kDa and ON in the same SDS\PAGE bands, detected by the respective antibody reactions in crude bone extracts which were extracted in the presence of alkylating agent. these differences may be attributed to the nature of the in itro system used and the interpretation of the physico-chemical data [16] [17] [18] . Further studies related to the importance of the phosphate groups were recently reported where phosphorylated and dephosphorylated forms of OPN and BSP were found to have different cell-binding capacity to osteoclasts [15] . The presence of an RGD (Arg-Gly-Asp) sequence region in both OPN and BSP found to be involved in cell binding led to the conclusion that these two proteins can regulate osteoblastic and osteoclastic cell activity during bone formation and resorption respectively [4, 5, 9, 10, 15, 19, 20] . Indeed, studies have confirmed that the RGD containing proteins promote cell attachment through interactions with α v β $ integrin receptors [11] [12] [13] . In addition, it has also been shown that the RGD sequence can initiate intracellular biochemical processes such as Ca# + signalling [14] and modulate cellular behaviour towards osteoclastic bone resorption [12] .
In studies from this laboratory, embryonic chick tibia has been shown to contain membrane-associated casein kinase II (CKII) activity that can phosphorylate 32 kDa bone phosphoprotein and dephosphorylated casein [21] . More recent series of studies defined categorically that the major protein kinase that phosphorylates OPN is a microsomal CKII (also referred to as factorindependent protein kinase) [22, 23] . The extensive quantitative analysis of the state of phosphorylation in in itro studies of both purified bovine bone OPN and BSP in their native and dephosphorylated states and using a series of purified protein kinases clearly defined that both of these secretory proteins are highly phosphorylated and contained 7n8 and 4n1 mol of phosphate\mol of naturally occurring OPN and BSP, respectively [24] . In this same study it was shown that dephosphorylated OPN and BSP can be phosphorylated by CKII, which adds 8n9 and 6n6 mol of phosphate\mol of OPN and BSP, respectively, with additional phosphorylation by protein kinase C and cGMPdependent protein kinase, each of the latter introducing about 1 mol of phosphate\mol of OPN or BSP. Further evaluation led to the conclusion that the majority of the phosphates on OPN resided on the N-terminal half of the molecule, which is the non-RGD domain, while for BSP all of the phosphates were concentrated on the N-terminal half [24] . Consistent with these, the precise sites of identification of $#P-labelled OPN secreted from cultured chicken osteoblasts indicated that the majority of the phosphorylation sites were those with recognition sequences towards CKII [25] . Overall, when these findings were assessed in conjunction with a recent report in which the phosphates on OPN and BSP were found to be important in osteoclast binding [15] , led to our postulate that osteoclast binding is strongly assisted by the highly phosphorylated N-terminal halves of both OPN and BSP, which are the non-RGD domains [24] . Hence, this in turn has led us to propose that the overall cell attachment\ modulation involved participation of (a) the RGD sequence region, (b) phosphorylated regions and (c) the non-RGD amino acid sequence KKAGDA, in a coupled fashion [24] . The regulation of the above biological functions therefore becomes dependent on the state and extent of phosphorylation of OPN and BSP, since this is a variable component.
Despite the extensive general studies carried out on the best characterized ECM phosphoproteins of bone, OPN and BSP, their precise biological functions are still unknown, and even less understood are the roles of the post-translational modification, in particular covalently bound phosphates. The number of bone ECM proteins being reported and characterized continues to increase, e.g. BSP, OPN, osteonectin (ON), osteocalcin (OC), matrix Gla protein, 75 kDa bone acidic glycoprotein (BAG-75), proteoglycan I (PG I), proteoglycan II (PG II), bone morphogenetic proteins, etc. However, these are still only a small number compared with the presence of over 200 unknown and uncharacterized proteins in the bone matrix [26] , of which perhaps there exist ECM non-collagenous proteins with some unique characteristics and very significant biological functions specific to bone still to be discovered.
The present study reports on isolation, purification and characterization of bone glycosylated phosphoprotein with unique amino acid sequences and physico-chemical characteristics hitherto undiscovered and\or undescribed. 
EXPERIMENTAL PROCEDURES

Tissue preparation and extraction
The cortical parts of calf tibiae (1-3 weeks postnatal) were crushed into powder and demineralized with HCl at a constant pH " 2n0 as described previously [27] . Normally 100 g of bone powder was processed with several repeats up to 1 kg in order to purify 0n2-1n0 mg quantities of each of the 80 kDa forms. The extraction including the following procedures was performed at 4 mC in 3-5 volumes of solvent relative to bone powder. After centrifugation, the residual demineralized bone powder was extracted with 0n5 M EDTA, 1n0 M NaCl in 50 mM Tris\HCl buffer, pH " 7n5, containing protease inhibitors (1 mM phenylmethylsulphonyl fluoride, 1 mM ε-amino-n-caproic acid, 1 mM p-hydroxymercuribenzoic acid, 1 mM benzamidine hydrochloride, 1 mM levamisole, 5 mM sodium pyrophosphate) and the pH was adjusted to " 7n5 by addition of solid Trizma base followed by extraction for 1 day. The residual bone powder was recovered by centrifugation and extracted for 24 h with 1n0 M NaCl, 50 mM Tris\HCl, pH " 7n5, containing the same protease inhibitors. The EDTA\NaCl and NaCl extracts were dialysed against distilled water for 1 day (extract : H # O l 1 : 30, v\v), lyophilized, and stored at k20 mC until use. Before any chromatographic step, the lyophilized extract was redissolved in 50 mM
Figure 1 DE-52 chromatography of EDTA/NaCl and NaCl extracts
The extracts were redissolved in 50 mM Tris/HCl, pH 7n4, concentrated by ultrafiltration over a YM10 membrane on ice, diluted with the same buffer and chromatographed on a DE-52 column as described in the text (A). An equal volume of the central portion of each fraction was electrophoresed and visualized with CBB (B). Tris\HCl buffer, pH 7n4, concentrated, diluted and reconcentrated using an Amicon ultrafiltration system with a YM10 membrane.
In a separate experiment, 0n1 g of bone powder was extracted for 10 days in a microcentrifuge tube containing 1 ml of 0n5 M EDTA, 1n0 M NaCl, 10 mM IA, protease inhibitors, 50 mM Tris\HCl, pH 7n7, by changing the solvent every 2 days. The extract was obtained by centrifugation. The residue was washed twice with 1n0 M NaCl, protease inhibitors, 50 mM Tris\HCl, pH 7n4, then 3 times with 0n15 M NaCl, protease inhibitors, 50 mM Tris\HCl, pH 7n4, and placed for 24 h in 150 µl of the latter buffer containing 50 mM DTT. The supernatant was obtained by centrifugation and frozen until use. In the same way, the control NaCl extract was prepared in the absence of DTT.
Column chromatography
A DE-52 column (0n9i6n0 cm) was eluted at 4 mC either in 50 mM Tris\HCl, pH " 7n5, using a linear gradient from 0n1 to 0n5 M of NaCl followed by a stepwise elution at 0n7 M NaCl or in 7 M urea, 50 mM Tris\HCl, pH " 7n5, using a linear gradient (0n05-0n2 M) at a flow rate of 1 ml\min and monitored continuously at 280 nm. Fractions of 2n0 ml were collected. A HAP column was run at 4 mC by a linear gradient (0n02-0n2 M) and a stepwise (0n6 M) gradient of KH # PO % (pH 6n8). Further purification was done on a TSK-3000 HPLC in 7 M urea, 0n4 M NaCl, 50 mM KH # PO % , pH 6n8, at room temperature. This latter chromatography was repeated for the final purification. ON was purified on DE-52, HAP and TSK-3000 HPLC columns in the absence of urea and DTT. Commercial BSA was passed through the TSK-3000 HPLC column in 0n4 M NaCl, 50 mM KH # PO % , pH 6n8, before use. Each of the purified proteins was concentrated and the buffer was changed to deionized distilled water containing 2 mM NaCl (" 10 ml final volume) and freeze-dried. BSP was purified by chromatography as described previously [24] .
SDS/polyacrylamide gel electrophoresis (SDS/PAGE ) and Western blotting
SDS\PAGE was carried out by the method of Laemmli [28] , using 7n5 % and 10 % mini-gels (1n5i55i80 mm) at 9 mA for " 4 h. All the samples were treated with β-mercaptoethanol unless indicated otherwise. The gels were stained with CBB or with Rhodamine B following the method of Debruyne [29] . In another set of experiments, the proteins separated in 7n5 % gels were transferred to nitrocellulose membranes and immunodetected as described previously except gelatin was used for the blocking solution [30] .
Antibody preparation
Antibody to the protein of interest was raised in a rabbit by cutting the corresponding band from SDS\PAGE gels as described elsewhere with some modifications [30] . About 200 µg of the purified protein were electrophoresed in 10 lanes in a 7n5 % mini-gel. The protein bands were visualized with CBB, collected and lyophilized. The dried gels were cut into small pieces ( 0n5 mm) with scissors and used for two injections (two-thirds for the first time). The second injection was given 2 weeks later and the antiserum was obtained 4 weeks after the first injection.
Internal peptide generation and isolation
The purified 80 kDa protein (" 20 µg) was partially digested with trypsin (2 % w\w) in 0n5 ml of 0n1 M NH % HCO $ at 37 mC for 3 h and lyophilized. The peptides were isolated by RP-HPLC on a C18 column using a linear gradient from H # O\0n1 % (v\v) trifluoroacetic acid (TFA) to 60 % CH $ CN\0n055 % TFA (v\v) in 60 min at a flow rate of 0n5 ml\min. The column was washed for 10 min with H # O\0n1 % TFA after injection followed by the above gradient. Fractions of 0n5 ml were collected and absorbance at 219 nm was continuously recorded. The separated peptides were concentrated using a SpeedVac freeze-drier and stored at k20 mC until analysis.
Amino acid composition and N-terminal sequence analysis
The purified proteins were each hydrolysed in 6 M HCl in sealed Pyrex tubes for 2 and 24 h for phosphoamino acid and total amino acid analyses, respectively. The hydrolysates were analysed using a Waters HPLC system for phosphoamino acid as described previously [24] and a Beckman Model 121-M amino acid analyser for total amino acid detection following instructions accompanying the analyser. The N-terminal and internal sequences were determined using an Applied Biosystem Model 477A automated sequenator as described previously [24] .
Protein, neutral sugar and sialic acid determination
The purified protein (" 100 µg) was each dissolved in 10 mM DTT, 0n1 M NH % HCO $ . An aliquot was used for protein assay by the method of Read and Northcote [31] , using chicken ovalbumin as standard. Neutral sugars and sialic acid were determined as reported previously [32, 33] . -(j)-glucose and N-acetylneuraminic acid were used as standards.
Evaluation of disulphide bond formation
(i) About 50 µg of protein from the crude bone extracts (isolated in the absence of IA and DTT or in the presence of IA or DTT) was treated for 2 h at room temperature (" 22 mC) with 40 µl of 8 M urea, 0n2 M Tris\HCl, pH 8n0, in the absence and presence of 30 mM DTT. (a) The sample without DTT was alkylated by 30 mM IA for 30 min at the same temperature, and (b) the sample with DTT was treated with 90 mM IA, since this sample contained 30 mM DTT equivalent to 60 mM free thiol groups, which would consume 60 mM of IA, the remaining 30 mM IA is as in (a). (ii) The purified 80 kDa protein (5 µg) and ON (10 µg) were incubated in 40 µl of 0n155 M KCl, 10 mM Hepes, 0n01 % streptomycin sulphate, pH 7n4 at 37 mC for 3 days. After centrifugation, the supernatant was alkylated with 20 µl of 8 M urea, 0n2 M Tris\HCl, pH 8n0, containing 30 mM IA. The residue was washed three times with 0n155 M KCl, 10 mM Hepes, 0n01 % streptomycin sulphate, pH 7n4, and extracted with 15 µl of the same buffer containing DTT (final 30 mM) at 37 mC for 60 min. The supernatant was obtained by centrifugation and mixed with 25 µl of 8 M urea, 0n2 M Tris\HCl, pH 8n0, containing 90 mM IA for alkylation. As controls, ON and BSA were treated in the same way. All the above samples were incubated with 10-20 µl of 8 M urea, 15 % sugar, 2 % SDS, 50 mM Tris\HCl, pH 6n8, at 100 mC for 3 min, subjected to SDS\PAGE, and visualized by CBB staining or Western blotting.
RESULTS
Extraction and purification of the 80 kDa protein
Most of the mineral-binding proteins such as OPN, BSP, OC and blood-derived albumin, major non-collagenous ECM components of bone are extracted by acid demineralization [24, 34] . In contrast, the 80 kDa protein and most of ON were still in the HCl residue composed mainly of type-I collagen and extracted with 0n5 M EDTA\1n0 M NaCl, pH " 7n5. The 80 kDa protein was not readily observed in EDTA\NaCl extract by SDS\PAGE due to the presence of predominant ON, 55 and 65 kDa proteins unless the extract was chromatographed on a DE-52 ionexchange column (Figure 1) .
The 80 kDa protein was coeluted with a variety of proteins having molecular weights of about 30, 43 (ON), 47, 55, 65, 95 and 120 kDa on the DE-52 column in 50 mM Tris\HCl, pH 7n4 ( Figure 1) . Interestingly, the 80 kDa protein was eluted in two peaks which were divided into three fractions designated as 80 k-I, 80 k-II and 80 k-III on the DE-52 column under nondenaturing conditions when a shallow linear gradient was used (Figure 1 ). The prevailing ON was also eluted in the same manner ; had not been reported for ON, suggesting the heterogeneity of ON, as in the case of the 80 kDa protein as discussed later. A similar elution pattern was observed for the 55 and 65 kDa proteins, however, they appeared earlier.
The 80 k-I fraction was further separated on a HAP column into two different HAP-affinity forms, 80 k-I-1 and 80 k-I-2 ( Figure 2A ). The 47, 95 and 120 kDa proteins were removed by HAP chromatography (Figure 2) . The eluting concentrations for
Figure 4 TSK-3000 HPLC of the partially purified 80 kDa protein
Fraction 80 k-I-1 ( Figure 3A ) was concentrated and brought into 7 M urea, 0n4 M NaCl, 20 mM DTT, 50 mM KH 2 PO 4 , pH 6n8 and chromatographed on a TSK-3000 HPLC in the same buffer without DTT at room temperature as described in the text (A). The fraction containing 80 kDa protein was rechromatographed (B). Similarly, chromatograms C, E and G were obtained from fractions 80 k-I-2 ( Figure 3B ), 80 k-II ( Figure 3C ), 80 k-III ( Figure 3D ) and the final purified chromatograms were D, F and H, respectively. Proteins were electrophoresed and stained with CBB (insets). Five µg of the purified protein as applied. k/j Indicates without or with β-mercaptoethanol when samples were heated at 100 mC.
80 k-I-1, 80 k-I-2, 80 k-II and 80 k-III were 0n08-0n11, 0n12-0n15, 0n04-0n07 and 0n09-0n14 M KH # PO % , respectively. The predominant components, 55 and 66 kDa proteins were almost completely removed on the DE-52 column in the presence of urea and DTT (Figure 3) . After TSK-3000 HPLC, a single broad band for the four forms of the 80 kDa protein was observed around 80 kDa on SDS\PAGE gels under the reducing conditions together with small amounts ( 2 %) of a " 43 kDa contaminant protein in the 80 k-I-1 and -II, which was identified as ON as described later (Figure 4) . However, under the non-reducing con- ditions three more bands appeared, probably dimer, trimer and tetramer of the 80 kDa protein while the 43 kDa protein disappeared. The approach of extraction and purification used here provided " 0n3, 0n2, 0n9 and 0n8 mg of 80 k-I-1, 80 k-I-2, 80 k-II and 80 k-III per 1 kg of wet bone powder, respectively. In comparison, 20 mg of BSP, 5 mg of OPN [24] and 3n5 mg of 18 kDa lysine-rich protein (a growth and differentiation factor) [19] were obtained from 1 kg of wet bovine bone.
Amino acid compositions and sequences of the 80 kDa protein
Both 80 k-I-2 and -III had similar amino acid composition (Table 1) , sharing high contents of Asx and Glx similar to other Ca# + \HAP-binding bone proteins such as OPN, BSP, ON, and OC. However, unlike these proteins, the 80 k-I-2 and -III contained strikingly high content of leucine residue, 120, 115 per 1000 total amino acid residues. These features are reminiscent of PG I (biglycan) and PG II (decorin) ( Table 1) . Also, the two forms of the 80 kDa protein were shown to be rich in cysteine (Table 1 ). All four forms of the 80 kDa protein had the same Nterminal sequence (Table 1) . Partial tryptic digestion of the 80 k-III generated eight internal peptides as separated by C18 HPLC ( Figure 5 ). Four of the peptides were sequenced. Peptide 1 contained two N-terminal sequences at a ratio of " 2 : 3 (Table  1) . Interestingly, peptides 6, 7 and 8 were shown to be different but contain the same region, IFLGXXEI. No sequences similar to these N-terminal and internal sequences were found in the non-redundant GenBank CDS translationsjPDBjSwissProtj SPupdatejPIR database, when the computation was performed at the National Center for Biotechnology Information using the Blast network service. When Swiss Prot database using the  program in the Wisconsin package was used low homology sequences were defined towards a single internal peptide, however, combination of the internal peptides and the Nterminal sequences could not be matched to a known protein.
Post-translational modifications of the 80 kDa protein
Post-translational modifications in proteins are a common phenomenon. So far collagen cross-linking, phosphorylation,
Figure 5 RP-HPLC of the trypsin-treated 80 k-III
The purified 80 k-III was partially digested with trypsin and chromatographed by RP-HPLC on a C18 column as described in the text.
glycosylation, sulphation, γ-carboxylation, transglutaminasecatalysed cross-linking, etc. have been reported for bone ECM proteins. When we examined whether the 80 kDa protein undergoes such modifications, we found that 80 k-I-2 and -III contained 7 and 16 phosphoserines per 1000 total amino acid residues, respectively (Table 2) ; the latter is close to that of BSP. The 80 k-I-1 and -II were stained to an extent similar to BSP with Rhodamine B, an indicator of phosphoproteins ( Figure 6 ). The four forms of the 80 kDa protein were also shown to contain different contents of neutral sugars and sialic acid ( Table 2) .
Evaluation of intermolecular disulphide formation
Surprisingly, SDS\PAGE showed that three bands of higher molecular weights, apparently consistent with dimers, trimers and tetramers of the 80 kDa protein, were observed in all different forms of the purified 80 kDa protein under the non-reducing conditions and disappeared when reduced (Figure 4, insets) . Similarly ON, rich in cysteine, also formed polymers, when the purified ON was incubated for 3 days at 37 mC under physiological . ON has been shown to migrate faster on SDS\PAGE gels under non-reducing (" 40 kDa) than under reducing conditions (" 43 kDa) [35] . Our data also revealed the same result when ON was incubated for less than 60 min at 37 mC ( Figure 1B and Figure 7 , lane 2), except the molecular weight was a little larger (" 46 kDa) in the 7n5 % gels in the presence of reducing agent ( Figure 7 , lane 1). The 43 kDa contaminant protein ( 2 %) in the purified 80 k-II showed positive reaction with anti-ON antibody and an additional band at " 95 kDa was also found, which was not visible in the CBB-stained gels ( Figure  9 , lane 1). When 80 k-II was added during the incubation of purified ON for 3 days under physiological conditions, two new high M r bands were observed in the stacking gels and just below the border of stacking and running gels ( Figure 9, lane 9) . Also, the density of ON dimer and trimer bands decreased and the tetramer and pentamer disappeared. Furthermore, ON was 
DISCUSSION
More than 200 non-collagenous ECM proteins have been shown to exist in bone by two-dimensional gel electrophoresis [26] . However, to date only a few have been purified and characterized.
In the present study we report on isolation and characterization of an 80 kDa glycosylated phosphoprotein with unique physicochemical characteristics hitherto undescribed for any of the known bone proteins. Both the unusual characteristics and the N-terminal and internal amino acid sequences of the 80 kDa protein were unmatched to any known protein, indicating that this protein is another novel component of the bone. The separation characteristics of the 80 kDa protein on anionexchange and HAP columns led to purification of four different forms, 80 k-I-1, -2, -II, and -III with the same N-terminal sequence and almost the same molecular weight, suggesting evidence of four isoforms resultant from different degrees of post-translational modification. This was supported by the quantitative analyses of covalently-bound phosphates and carbohydrates (Table 2) . Although the amino acid composition indicated similarities to PG I and PG II (Table 1) , ABC chondroitinase has no effect on the 80 kDa protein (data not shown). Sato et al. [36] have reported an 80 kDa acidic glycoprotein from bovine bone and this protein can be separated from ON on a DEAE-Sephacel column. However, the 80 k-I-1, -I-2, -II, and -III could not be separated from ON on a DE-52 column, and the amino acid contents of Ile, Leu and His in both 80 k-I-2 and -III are almost double that in the 80 kDa acidic glycoprotein. Also, neither polymer formation nor HAP-binding has been shown for the 80 kDa acidic glycoprotein. These data indicate that the 80 kDa protein in the present work is different from the previously reported 80 kDa acidic glycoprotein. The importance of the covalently-bound phosphate groups on the ECM proteins as discussed in the Introduction combined with our extensive studies on the state and sites of phosphorylation of OPN and BSP suggest significant roles of phosphates in the biology of bone. The domains that contain the majority of the phosphates of OPN and BSP and the determination of the precise sites of phosphorylation with variations of the extent of phosphorylation on each site between 30 and 100 % [25] , led to the postulate that an important and a wide range of biological functions of these ECM molecules may be exerted frequently by their state of phosphorylation [25] . Whether the isomeric forms of 80 kDa proteins with different extents of phosphorylation present such behaviour is yet to be determined. However, it is clear that the 80 kDa glycosylated phosphoprotein we are reporting on in the present work follows very closely the state and varying degrees of phosphorylation exemplified by OPN and BSP, including the heterogeneity of the protein from the chromatographic elutions, with the overall amount of phosphates on 80 kDa protein more closely correlated with that of BSP than OPN. The phosphate groups may contribute to the affinity of 80 kDa protein for HAP as well as a possible regulatory effect on mineral deposition analogous to those postulated for OPN and BSP. However, the ability of the 80 kDa protein to form polymers through intermolecular disulphide formation as discussed below sets this unique protein apart from OPN and BSP, with possible yet unknown additional functionalities.
Under the non-reducing conditions, three high M r bands ( 100 kDa) were observed in all different forms of the purified 80 KDa protein (Figure 4 , insets), indicating that these proteins contain free thiol groups which can participate in ' intermolecular ' disulphide bond formation in an appropriate environment to form polymers. The 80 k-I-2 and -III forms appear to form polymers more easily than 80 k-I-1 and -II since the partially purified former fraction contained larger amounts of high M r fraction ( 80 kDa), observed as an 80 kDa band in reducing SDS\PAGE, which was obtained in the second gel chromatography (Figure 4) . ON can also undergo polymerization in a similar manner ( Figure 9, lane 8 ). This inconsistency with the previous report [35] , is due to the reaction time over which observations were made. In contrast, BSA, which also contains a large number of cysteine residues, cannot form disulphidebonded polymers under the same conditions ( Figure 7 , lane 4). The intermolecular disulphide cross-links between the same protein molecules to form complexes have been previously reported, e.g. fibronectin [37] ; however, such occurrences are of low frequency in nature. Since both the 80 kDa protein and ON are coeluted chromatographically (Figures 1-3 ) and the purified proteins have the ability to form homo-oligomers in itro through disulphide bonds, it is possible that these two proteins may undergo disulphide interchange to form hetero-oligomer complexes. To address this question, purified ON was incubated with the purified 80 kDa protein under physiological conditions, which led to the appearance of two additional bands with a higher M r than those of ON and that of the 80 kDa protein (Figure 9,   lanes 8, 9 ; Figure 8, lane 1) , indicating the disulphide bond formation between these two proteins. Such interactions between the 80 kDa protein and ON appear to take place in i o as determined in experiments not treated by DTT and when alkylating agent was used at the time of extraction. To prevent the thiol-disulphide and disulphide-disulphide interchange, of which the former can occur at neutral pH and the latter at acidic, IA and alkaline pH were used at the time of extraction. Westernblot analyses of the extracts using anti-80 kDa protein and anti-ON showed that multiple high M r bands ( 90 kDa) were reactive in each of these bands toward both antibodies under non-reducing conditions and most of these bands disappeared in the presence of reducing agent (Figure 8, lanes 3, 5 ; Figure 9,  lanes 3, 5, arrows) . The same results were obtained in the extract without IA treatment during extraction ( Figure 8 , lanes 2, 4 ; Figure 9 , lanes 2, 4, arrows), indicating that the intermolecular disulphide bond complexes between 80 kDa and ON existed naturally in the bone matrix.
The existence of insoluble, intermolecular disulphide-bonded complexes of ON was supported from the results in the present study where (a) ON was coextracted with the 80, 55 and 65 kDa proteins from the insoluble EDTA\NaCl residue in the presence of DTT ( Figure 7 , lane 8 ; Figure 8 , lane 7 ; Figure 9 , lane 7) and (b) ON and the 80 kDa protein formed insoluble complexes under physiological conditions which were solubilized by DTT treatment ( Figure 9 , lane 11). These data suggest that the intermolecular disulphide-bond formation is required for these proteins to provide insoluble complexes. Such insoluble forms are probably important for different functions of these proteins, since there is sufficient evidence to suggest that certain bone ECM proteins in an insoluble state can induce mineral deposition, while the soluble forms lack such properties [35, 38, 39] . Selfassociation to form large macromolecular complexes has been reported for BAG-75 [40] ; however, these complexes were apparently of the non-covalent type and can be prevented by denaturants such as SDS alone. The multiple functions of ON that have been postulated [19, [41] [42] [43] suggest that the disulphidebonded complex formation of ON and the 80 kDa protein are highly likely to be important in modulating such activities of ON and other biological functions in bone as yet unknown. It is noteworthy that the intermolecular disulphide bonds between monomers of different ECM proteins in bone forming ' heterooligomers ' has not been reported to date.
In summary, the findings in the present work indicate that the 80 kDa protein is another novel component of non-collagenous ECM proteins of bone. The protein undergoes the same posttranslational modifications, such as glycosylation and phosphorylation as those well-known and characterized ECM proteins of bone, e.g. OPN, BSP, BAG-75 and ON. However, the 80 kDa protein has unique characteristics not shared by these proteins, i.e. it possesses ability to form polymers with itself through disulphide bonds, and intermolecularly disulphide bonds to ON resulting in possible new structures and functions that set this 80 kDa protein apart from any of the thus far characterized bone non-collagenous ECM proteins, with possible unique and important biological functions specific to bone as yet undetermined.
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